Search

everythinglearnresearchcommunity

for

Search:↓

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The combined therapy improved fertility in women with PCOS, especially in certain types.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Acupuncture reduces anxiety and depression in women with PCOS.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Finasteride reduces hair growth better, but spironolactone has more side effects.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

PCOS women with COVID-19 have higher cardiometabolic risks.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Glioma treatment may improve with new therapies and technologies.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Finasteride, a hair loss medication, was found to be safe and effective in improving hair quality and stopping hair loss in men with early-onset baldness.